VALYSTR · Stock research
Listed on NYSE American. What the market is pricing into Pelthos Therapeutics Inc. (PTHS) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Biotechnology · market value about $41.3M · revenue $43.3M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows